Diabetes and metabolism Archives - Page 3 of 6

Podcasts

Finerenone for chronic kidney disease in type 2 diabetes

In this podcast, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

Podcasts

Practical guide to tirzepatide – Lecture

In this Healthed lecture, A/Prof Samantha Hocking provides an update on what this new treatment is.

Videos

Finerenone for chronic kidney disease in type 2 diabetes

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

Clinical Articles

Is diabetes remission really as hard to achieve as a new study suggests?

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

Clinical Articles

Preventing DKA in kids – tips to make a timely type 1 diabetes diagnosis

Cases of diabetic ketoacidosis (DKA) in children are on the rise in Australia, sometimes with tragic consequences, says paediatric endocrinologist A/Prof Gary Leong—and empirical evidence supports this observation.

Podcasts

Weight loss for better type 2 diabetes outcomes – Your questions answered

The questions answered in this podcast are listed. They were compiled by GPs and health professionals around Australia regarding weight loss for better type 2 diabetes outcomes.

Clinical Articles

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Clinical Articles

Ozempic drought continues

Worldwide shortages cause to TGA put the brakes on prescribing

Expert/s: Healthed

Clinical Articles

Body mass index: why practitioners are relying on it less when looking at a patient’s health

ody mass index has long been used by doctors as the standard method for measuring health – and often still is.

Expert/s: Healthed

Clinical Articles

WHO’s recommendation against the use of artificial sweeteners for weight loss leaves many questions unanswered

Do low-calorie sweeteners help with weight management? And are they safe for long-term use?

Podcasts

Bariatric surgery options for obesity

Obesity is the disease of our generation- managing obesity and the complications of obesity to suit each individual patient's requirements and needs.

Clinical Articles

GLP-1s for T2D – the earlier the better?

Experts say GLP-1 RAs should be prescribed more often and earlier, citing compelling benefits for type 2 diabetes—but the PBAC has other ideas.

Diabetes and metabolism

Finerenone for chronic kidney disease in type 2 diabetes

In this podcast, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

Practical guide to tirzepatide – Lecture

In this Healthed lecture, A/Prof Samantha Hocking provides an update on what this new treatment is.

Finerenone for chronic kidney disease in type 2 diabetes

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

Is diabetes remission really as hard to achieve as a new study suggests?

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

Preventing DKA in kids – tips to make a timely type 1 diabetes diagnosis

Cases of diabetic ketoacidosis (DKA) in children are on the rise in Australia, sometimes with tragic consequences, says paediatric endocrinologist A/Prof Gary Leong—and empirical evidence supports this observation.

Weight loss for better type 2 diabetes outcomes – Your questions answered

The questions answered in this podcast are listed. They were compiled by GPs and health professionals around Australia regarding weight loss for better type 2 diabetes outcomes.

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Ozempic drought continues

Worldwide shortages cause to TGA put the brakes on prescribing

Body mass index: why practitioners are relying on it less when looking at a patient’s health

ody mass index has long been used by doctors as the standard method for measuring health – and often still is.

WHO’s recommendation against the use of artificial sweeteners for weight loss leaves many questions unanswered

Do low-calorie sweeteners help with weight management? And are they safe for long-term use?

Bariatric surgery options for obesity

Obesity is the disease of our generation- managing obesity and the complications of obesity to suit each individual patient's requirements and needs.

GLP-1s for T2D – the earlier the better?

Experts say GLP-1 RAs should be prescribed more often and earlier, citing compelling benefits for type 2 diabetes—but the PBAC has other ideas.

Get the app

Site

Company

Connect

Legal

Healthed

Diabetes and metabolism

In this podcast, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

In this Healthed lecture, A/Prof Samantha Hocking provides an update on what this new treatment is.

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

Cases of diabetic ketoacidosis (DKA) in children are on the rise in Australia, sometimes with tragic consequences, says paediatric endocrinologist A/Prof Gary Leong—and empirical evidence supports this observation.

The questions answered in this podcast are listed. They were compiled by GPs and health professionals around Australia regarding weight loss for better type 2 diabetes outcomes.

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Worldwide shortages cause to TGA put the brakes on prescribing

ody mass index has long been used by doctors as the standard method for measuring health – and often still is.

Do low-calorie sweeteners help with weight management? And are they safe for long-term use?

Obesity is the disease of our generation- managing obesity and the complications of obesity to suit each individual patient's requirements and needs.

Experts say GLP-1 RAs should be prescribed more often and earlier, citing compelling benefits for type 2 diabetes—but the PBAC has other ideas.

Get the app

Site

Company

Connect

Legal

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed